Applied Clinical Trials
Bristol-Myers Squibb’s cardiovascular development leader discusses the importance of diversifying clinical trials for better patient outcomes.
Christen Harm
Advertisement
Christen Harm is Pharmaceutical Executive's Associate Editor. Email her at charm@mmhgroup.com
Articles by Christen Harm
Advertisement
Latest Updated Articles
Creating Medicines ‘Appropriate for All’September 1st 2019
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Comparing OpenAI and Mistral on Clinical Trial Matching
2
Embedding AI Across the Clinical Operating Model: Q&A with Rajneesh Patil, Syneos Health
3
From Complexity to Endpoint Meaningfulness: Addressing Key Neuroscience Trial Challenges with eCOA
4
ACT Brief: Community Research Financing Gaps, Neuroscience Endpoint Data, and Teva’s Biosimilar Deal
5